Effect of Shock Wave–Facilitated Intracoronary Cell Therapy on LVEF in Patients With Chronic Heart Failure: The CELLWAVE Randomized Clinical Trial

Study Questions:

What is the effect of targeted cardiac shock wave pretreatment with subsequent application of bone marrow–derived mononuclear cells (BMCs) on recovery of left ventricular ejection fraction (LVEF) in patients with chronic heart failure (CHF)?